Humane endpoints, body weight (g) at the beginning and at the end of the study, weight gain (%), average daily consumption of the food (g) and drink (mL) during the experimental trial (mean ± standard deviation)

GroupHumane endpointsBody weightWeight gain (%)Average daily consumption
Initial (g)Final (g)Food (g)Drink (mL)
G1 WT water0.08 ± 0.1829.65 ± 1.6131.54 ± 3.296.24 ± 7.184.025.07
G2 HPV water0.36 ± 0.41127.91 ± 3.1928.69 ± 3.842.60 ± 3.654.246.46
G3 WT 0.013 g/mL0.24 ± 0.2225.24 ± 1.2726.72 ± 0.955.92 ± 2.194.265.18
G4 HPV 0.006 g/mL1.04 ± 0.09223.83 ± 1.9825.07 ± 2.003.12 ± 4.723.506.60
G5 HPV 0.008 g/mL0.36 ± 0.2628.21 ± 4.7328.99 ± 4.245.38 ± 6.744.298.01
G6 HPV 0.013 g/mL0.80 ± 0.4024.44 ± 3.6226.68 ± 3.899.24 ± 3.284.077.69

1 Statistically different from G4 (P < 0.05). 2 Statistically different from G5 (P < 0.05). G1 are wild-type (WT) mice that drink water; G2 are mice with human papillomavirus (HPV) that drank water; G3 are WT that drank daily an aqueous extract of Aloysia citrodora at a concentration of 0.013 g/mL; G4 are mice with HPV that drank daily an aqueous extract of A. citrodora at a concentration of 0.006 g/mL; G5 are mice with HPV that drank daily an aqueous extract of A. citrodora at a concentration of 0.008 g/mL; G6 are mice with HPV that drank daily an aqueous extract of A. citrodora at a concentration of 0.013 g/mL